Stay updated on Naptumomab + Durvalumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer now shows Revision: v3.3.3, and references to HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. This is a minor administrative update that does not affect the study data or page content.
    Difference
    0.2%
    Check dated 2025-12-23T12:35:50.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The study status changed from Recruiting to Active, not recruiting, indicating no current enrollment. New sections for Contacts/Locations and Oversight were added to the study record.
    Difference
    0.9%
    Check dated 2025-12-01T20:30:37.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed in the page history. This does not alter study content or status.
    Difference
    0.1%
    Check dated 2025-11-24T17:05:12.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The government funding-related operating status notice was removed from the page header; this is an administrative update and does not alter study content or available data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-17T15:05:50.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The new screenshot shows only cosmetic/layout updates to the page header and navigation, and core study details appear unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:34:20.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Adds a government-funding notice with operating-status guidance and announces a software version upgrade to v3.2.0, replacing the previous v3.1.0.
    Difference
    11%
    Check dated 2025-10-05T10:30:29.000Z thumbnail image

Stay in the know with updates to Naptumomab + Durvalumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.